Home524663 • BOM
add
Bharat Immunologicals&Biologcls Corp Ltd
Previous close
₹23.33
Day range
₹23.12 - ₹23.44
Year range
₹19.00 - ₹35.88
Market cap
1.01B INR
Avg Volume
61.06K
P/E ratio
-
Dividend yield
-
Primary exchange
BOM
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 47.23M | — |
Net income | -49.18M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -46.86M | — |
Effective tax rate | 26.00% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 89.09M | — |
Total assets | 1.88B | — |
Total liabilities | 1.09B | — |
Total equity | 787.09M | — |
Shares outstanding | 43.14M | — |
Price to book | 1.28 | — |
Return on assets | — | — |
Return on capital | -7.59% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -49.18M | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Bharat Immunologicals and Biologicals Corporation Limited is a Public Sector Undertaking of the Government of India. Established in 1989 in Bulandshahar, Uttar Pradesh, BIBCOL manufactures oral polio vaccines and other immunisers. The company formulates over 12.5 crore doses of OPV and had aggregated revenues of ₹30.5 crore in fiscal 2006.
BIBCOL is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology. Wikipedia
Founded
1989
Website
